On your marks, get set… start-up!
Translation of research into clinical benefit for patients is vital if we are to beat cancer – but how, exactly, do you do that? Cancer Research UK's...
Translation of research into clinical benefit for patients is vital if we are to beat cancer – but how, exactly, do you do that? Cancer Research UK's...
Translation of research into clinical benefit for patients is vital if we are to beat cancer – but how, exactly, do you do that? Cancer Research UK's...
What was it like to take part in the first Eureka oncology-focused training – delivered in partnership with Cancer Research UK 36 participants from...
For researchers with novel insights into cancer biology that can be targeted therapeutically to treat cancer
Our second Innovation Summit took place in Alderley Park in Manchester in 2019. The event featured several researcher entrepreneurs as guest speakers...
The first Innovation Summit was held in London in 2018. Over 200 researchers gathered to gain insight into entrepreneurship and learned a key lesson:...
Storm Therapeutics is a University of Cambridge spinout developing first-in-class small molecule inhibitors of RNA modifying enzymes in oncology...
PsiOxus was formed in 2010 through the merger of Myotec and Hybrid Biosystems. Its principal expertise lies in the modification of natural organisms...
A team led by Professor Steven Jackson together with CRUK and the University of Cambridge founded Mission Therapeutics in 2011 to commercialise expert...